IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis

Clinical and Experimental Immunology

Volumn 133, Issue 2, 2003, Pages 283-289

  Schwarze, C ^a   Terjung, B ^a   Lilienweiss, P ^a   Beuers, U ^b   Herzog, V ^a   Sauerbruch, T ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ANCA; IIF; Immunoglobulin A; Liver disease

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLUORESCENCE; HUMAN; IMMUNOPATHOGENESIS; LIVER DISEASE; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED;

EID: 0041665087     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02195.x     Document Type: Article

References (42)

1. Roozendaal C, Kallenberg CGM. Anti-neutrophil autoantibodies (ANCA) in autoimmune liver diseases. Hepato-Gastroenterology 1999; 46:3034-40.
2. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (Suppl. 6):12-3.
3. Davies DJ, Moran JE, Niall NF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982; 285:606.
4. Woude van der FJ, Lobatto S, Permin H et al. Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425-9.
5. Targan S, Landers C, Vidrich A, Czaja AL. High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 1995; 108:1159-66.
6. Zauli D, Ghetti S, Grassi A et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997; 25:1105-7.
7. Mulder AHL, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17:411-7.
8. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993; 99:277-81.
9. Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and Ig G sub-class. J Hepatol 1996; 24:581-6.
10. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
11. Terjung B, Herzog V, Worman HJ et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders co-localize with nuclear lamina proteins. Hepatology 1998; 28:332-40.
12. Savige J, Gillis D, Benson E et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999; 111:507-13.
13. Peen E, Almer S, Bodemar G et al. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease. Gut 1993; 34:56-62.
14. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33:1370-5.
15. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-62.
16. Ellerbroek PM, Oudkerk Pool M, Ridwan BU et al. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994; 47:257-62.
17. Gigase P, De Clerck LS, Van Cotthem KA et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies. Dig Dis Sci 1997; 42:2171-4.
18. Esteve M, Mallolas J, Klaassen J et al. Factors related to the presence of IgA class antineutrophil cytoplasmic antibodies in ulcerative colitis. Am J Gastroenteroi 1998; 93:615-8.
19. Müller-Ladner U, Gross V, Andus T et al. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease. Eur J Gastroenteroi Hepatol 1996; 8:579-84.
20. Roozendaal C, de Jong MA, van den Berg AP, van Wijk RT, Limburg PC, Kallenberg CG. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol 2000; 32:734-41.
21. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999; 30:325-32.
22. Wiesner RH. Diagnostic criteria, clinical manifestations and natural history of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nisioka M, eds. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science Publisher BV, 1998:381-412.
23. Kim WR, Therneau TM, Wiesner RH et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 2000; 75:688-94.
24. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-38.
25. Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies using immunofluorescence microscopy. Clin Exp Immunol 2001; 126:37-46.
26. Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100:1385-91.
27. Roozendaal C, van Milligen de Wit AWM, Haagsma EB et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med 1998; 105:393-9.
28. Pokorny CS, Norton ID, McCaughan GW, Selby WS. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol 1994; 9:40-4.
29. Orth T, Gerken G, Kellner R, Meyer zum Buesschenfelde KH, Mayet WJ. Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 1997; 26:37-47.
30. Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Buesschenfelde KH, Mayet WJ. Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998; 112:507-15.
31. Roozendaal C, Zhao MH, Horst G et al. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol 1998; 112:10-4.
32. Walmsley RS, Zhao MH, Hamilton MI et al. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997; 40:105-9.
33. Sobajima J, Ozaki S, Uesugi H et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44:867-73.
34. Eggena M, Cohavy O, Parseghian MH et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000; 14:83-97.
35. Terjung B, Spengler U, Sauerbruch T, Worman HJ. Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50 kD nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119:310-22.
36. Mallolas J, Esteve M, Rius E, Cabré E, Gassull MA. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut 2000; 47:74-8.
37. Mestecky J, McGhee JR, Elson CO. Intestinal IgA system. Immunol Allergy Clin North Am 1988; 8:349-68.
38. Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 1995; 155:3262-7.
39. Kita H, Mackay IR, Van De Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001; 120:1485-501.
40. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology 1999; 30:351-7.
41. Czaja A, Homburger HA. Antibodies in liver disease. Gastroenterology 2001; 120:239-49.
42. Vierling J. Aetiopathogenesis of primary sclerosing cholangitis. In: Manns M, Chapman RW, Stiehl A, Wiesner R, eds. Primary sclerosing cholangitis. London: Kluwer Academic Publishers, 1998:37-45.